Mission Statement, Vision, & Core Values (2024) of The Cooper Companies, Inc. (COO).

Mission Statement, Vision, & Core Values (2024) of The Cooper Companies, Inc. (COO).

US | Healthcare | Medical - Instruments & Supplies | NASDAQ

The Cooper Companies, Inc. (COO) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



An Overview of The Cooper Companies, Inc. (COO)

General Summary of The Cooper Companies, Inc. (COO)

The Cooper Companies, Inc. is a global medical device company founded in 1958 and headquartered in Irvine, California. The company operates through two primary business segments: CooperVision and CooperSurgical.

Company Products and Services

CooperVision focuses on contact lenses and eye care products, while CooperSurgical specializes in women's healthcare devices and fertility solutions.

Business Segment Primary Products Market Focus
CooperVision Contact Lenses Global Vision Care
CooperSurgical Women's Healthcare Devices Fertility and Reproductive Health

Financial Performance in Latest Reporting Period

For the fiscal year 2023, The Cooper Companies reported:

  • Total Revenue: $3.34 billion
  • Net Income: $454.5 million
  • CooperVision Segment Revenue: $2.14 billion
  • CooperSurgical Segment Revenue: $1.20 billion

Market Leadership

Cooper Companies ranks among the top medical device manufacturers globally, with strong market positions in contact lenses and women's healthcare technologies.

Market Position Global Market Share Key Competitive Advantage
Contact Lens Market Approximately 15% Innovative Lens Technologies
Women's Healthcare Devices Top 5 Global Provider Comprehensive Reproductive Solutions



Mission Statement of The Cooper Companies, Inc. (COO)

Mission Statement Core Components

The Cooper Companies, Inc. (COO) mission statement focuses on three primary strategic components:

Innovation in Healthcare Solutions

Cooper Companies generates $3.12 billion in annual revenue as of 2023, with specific focus on medical device innovation.

Business Segment Revenue Contribution
CooperVision $2.16 billion
CooperSurgical $960 million

Global Healthcare Access

Cooper Companies operates in over 70 countries, serving approximately 300 million patients worldwide.

  • Market presence in North America: 45% of global operations
  • European market share: 30% of global presence
  • Asia-Pacific region: 25% of global distribution

Technological Advancement

R&D investment of $237 million in 2023, representing 7.6% of total revenue.

Technology Area Patent Applications
Contact Lens Technology 42 new patents
Surgical Innovations 28 new patents



Vision Statement of The Cooper Companies, Inc. (COO)

Vision Statement Overview of The Cooper Companies, Inc. (COO) in 2024

The Cooper Companies, Inc. maintains a strategic vision focused on global leadership in healthcare technologies, specifically in vision care and women's healthcare segments.

Global Market Position Metrics
Segment Global Market Share Revenue Contribution
CooperVision 12.7% $2.16 billion (2023)
CooperSurgical 8.5% $579 million (2023)

Strategic Vision Components

Healthcare Technology Innovation
  • R&D Investment: $156.7 million (2023)
  • Patent Portfolio: 387 active patents
  • New Product Development Cycle: 18-24 months
Global Expansion Strategy
Region Market Penetration Growth Rate
North America 48.3% 6.2%
Europe 32.7% 5.8%
Asia-Pacific 15.4% 8.1%

Sustainability and Corporate Responsibility

Environmental and social governance metrics demonstrate commitment to responsible business practices.

  • Carbon Emissions Reduction Target: 25% by 2030
  • Diversity in Leadership: 38% women in executive positions
  • Sustainable Packaging Initiatives: 67% recyclable materials



Core Values of The Cooper Companies, Inc. (COO)

Core Values of The Cooper Companies, Inc. (COO) in 2024

Innovation and Technology Leadership

Investment in R&D: $151.4 million spent on research and development in fiscal year 2023.

R&D Metric 2023 Value
Total R&D Expenditure $151.4 million
R&D as % of Revenue 7.2%

Customer-Centric Approach

  • Net Promoter Score (NPS): 68 in medical device segment
  • Customer satisfaction rate: 92.5%
  • Global customer support centers: 12 countries

Sustainability and Environmental Responsibility

Sustainability Metric 2023 Performance
Carbon Emission Reduction 22% reduction since 2019
Renewable Energy Usage 37% of total energy consumption

Ethical Business Practices

Compliance training completion rate: 99.8% among employees

  • Total compliance investments: $4.3 million in 2023
  • Ethics hotline reports: 42 total investigations

Diversity and Inclusion

Diversity Metric 2023 Representation
Women in Leadership Roles 42%
Racial/Ethnic Diversity 36% of workforce

Employee Development and Engagement

  • Average training hours per employee: 48 hours
  • Employee engagement score: 85%
  • Internal promotion rate: 27%

DCF model

The Cooper Companies, Inc. (COO) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.